It’s a “Three-Peat”: FDA Approves LEQSELVI (Deuruxolitinib) for the Treatment of Severe AA July 26, 2024
Mount Sinai Secures Large NIH Grant to Study JAK Inhibition in People with Down Syndrome and AA or AD July 11, 2024